AFP and testicular cancer: CtDNA detection of testicular cancer remained high, with an 84% sensitivity and 97% specificity for patients without established testicular cancer biomarkers, including alpha-fetoprotein, human chorionic gonadotropin, placental alkaline phosphatase, and lactate dehydrogenase [166].